We welcome Karla Childers to AI Uncovered . Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development. In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discuss...
Jun 03, 2025•29 min•Ep. 14
We’re excited to welcome Oeystein Kjoersvik to AI Uncovered . Oeystein leads the Generative AI program within the Quality Assurance team at Merck, where he focuses on developing AI tools and applying a quality-first approach to ensure safe, effective use of AI in GxP-regulated environments. In this episode, Tim and Oeystein delve into the challenges of adopting AI in regulated settings, the complexity of validating GenAI tools, and the transition from traditional processes to AI-augmented system...
Mar 31, 2025•33 min•Ep. 13
We’re thrilled to welcome Emmanuel Walckenaer , CEO of Yseop , back to AI Uncovered for a follow-up conversation on the rapid evolution of AI in biopharma. Since his last appearance, the industry has made significant strides in harnessing AI for regulatory submissions, clinical workflows, and medical writing—areas where Yseop is leading the charge in transforming content generation. In this episode, Tim and Emmanuel revisit the biggest AI breakthroughs of 2024 and explore how the pharmaceutical ...
Feb 20, 2025•24 min•Ep. 12
We welcome Meredith Brown-Tuttle to AI Uncovered . Meredith is the Chief Regulatory Strategist at Regulatorium, where she applies her 33 years of experience in the pharmaceutical and biologics industry. She specializes in working with small and medium-sized drug, biologic and combination product companies to navigate global regulatory strategy, intelligence and submission requirements. With a strong focus on innovation, Meredith is dedicated to revolutionizing regulatory science by integrating A...
Jan 13, 2025•29 min•Ep. 11
We welcome Michael Penlington to AI Uncovered. Michael has been working in Pharma for his entire career including roles in leading development of Vaccines and Clinical reporting at Novartis, as well as Senior Director roles of Science writing, Global Medical Writing and Medical Writing Center of Excellence at GSK. Most recently, Michael has taken on a new challenge as Director of Digital Clinical Development Solutions at Nurocor. In this episode, Tim and Michael discuss digital transformation in...
Aug 16, 2024•43 min•Ep. 10
We welcome Rohit Sood to AI Uncovered. Rohit is a seasoned executive with a strong background in commercialization and technology use in life sciences. He currently advises a variety of life science services and Private Equity firms on operations, growth and digital transformation. With over 25 years of experience in the life sciences and technology industries, Rohit has held multiple leadership roles, leveraging his expertise in AI, cloud computing and digital transformation. Rohit holds a degr...
Jul 02, 2024•45 min•Ep. 9
We welcome Fred Schonenberg to AI Uncovered. Fred is the founder and CEO of VentureFuel. He has created an innovation framework that bridges the VC, Angel, and Startup ecosystem with enterprises to deliver tangible technology solutions that drive growth. In his role at Venture Fuel, Fred has worked with over 100 companies from General Mills to Netflix. He is a frequent speaker at industry events such as SXSW, Ad Tech, and Advertising Week and is published in broad media publications including Hu...
Mar 04, 2024•37 min•Ep. 8
Welcome Sarah Tilly to AI Uncovered. Sarah is the Founder and Director of Azur Health Science, a regulatory writing consultancy based in France. Guided by her expertise as a member of the European Medical Writers Association (EMWA), Tim and Sarah discuss what steps are being taken to better understand the benefits of AI for medical writing. Sarah has been involved in medical writing since 2006 for a variety of companies and is the EMWA president-elect. She mentors and provides training to new me...
Nov 13, 2023•32 min•Ep. 7
We welcome Derek Kerton to AI Uncovered. Derek is the Founder and Chairman of the Autotech Council in Silicon Valley. His work brings global car companies together with startups to drive discussion around new technologies and their possible impact on the car industry. In this episode, Derek shares his expertise with Tim , offering valuable insights into the ever-evolving landscape of automotive tech. They discuss how cars are becoming safer and more efficient using innovation. They delve into gr...
Sep 04, 2023•44 min•Ep. 6
We welcome Daniel O'Mahony to AI Uncovered. Daniel is a senior manager of sales and business consulting with Körber Pharma, a pharma manufacturing software company. Along with his work at Körber, Dan lectures with the national institute of bioprocessing research and training and at the Atlantic Technical University covering topics like BioPharma 4.0 and digital transformation. In this episode, Tim and Dan look at the impact of AI on the pharmaceutical manufacturing processes and the delicate bal...
Jul 21, 2023•30 min•Ep. 5
We welcome Gregor Mittersinker to AI Uncovered. Gregor is the founder and creative director at Loft. Loft focuses on product development and design with a specialty in building large product ecosystems. In this episode, Tim and Gregor dive deep into UX and design. They discuss how LLMs, like ChatGPT, have impacted UI design, specifically around conversational UI and prompt interfaces. They evaluate how industry specific applications might use a variety of UI techniques to deal with the nuances o...
Jun 12, 2023•44 min•Ep. 4
We welcome Marjo Gazak to AI Uncovered. Marjo is a life sciences expert with over 22 years of experience in drug development, regulatory submissions, document development innovation and data mining systems. Tim and Marjo discuss a wide range of topics, from the emergence of automation in the drug delivery process to the future role of generative AI in helping this regulated industry get drugs to market faster. Marjo has worked at Eli Lilly and more recently at FibroGen, where she is the Senior D...
May 03, 2023•47 min•Ep. 3
The second episode features a conversation with Emmanuel Walckenaer , CEO of Yseop . Yseop is reimagining the future of scientific writing through generative AI. The company's mission is to get medicine into the hands of those who need it, faster. Tim and Emmanuel shares insights on the state of natural language generation (NLG) today and the roots of the technology. They discuss how generative AI is automating parts of the clinical document landscape and why the tech is helping scientific write...
Apr 03, 2023•29 min•Ep. 2
The first episode features a conversation with Craig Vachon , CEO of AI Redefined (AIR) and Head of US Operations at NextStage AM. Craig is an angel investor, author, TED speaker, and chairman of Yseop . Tim and Craig discuss the AI landscape as it exists today and then go into the benefits and limitations of ChatGPT and LLMs, especially for more regulated industries. They touch on some of the challenges involved with AI startups, advice for entrepreneurs, and practical considerations of rolling...
Mar 01, 2023•27 min•Ep. 1
Welcome to AI Uncovered , a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization. Hosted by Executive VP of Product at Yseop , Tim Martin leads a global team and ...
Feb 28, 2023•44 sec0
